Last updated: 9 September 2024 at 10:48am EST

Charles Farkas Net Worth




The estimated Net Worth of Charles Farkas is at least $1.53 Millón dollars as of 5 September 2024. Charles Farkas owns over 1,000 units of Conmed stock worth over $1,531,966 and over the last 10 years Charles sold CNMD stock worth over $0.

Charles Farkas CNMD stock SEC Form 4 insiders trading

Charles has made over 25 trades of the Conmed stock since 2015, according to the Form 4 filled with the SEC. Most recently Charles exercised 1,000 units of CNMD stock worth $39,640 on 5 September 2024.

The largest trade Charles's ever made was exercising 3,000 units of Conmed stock on 1 June 2016 worth over $220,110. On average, Charles trades about 931 units every 133 days since 2014. As of 5 September 2024 Charles still owns at least 20,880 units of Conmed stock.

You can see the complete history of Charles Farkas stock trades at the bottom of the page.



What's Charles Farkas's mailing address?

Charles's mailing address filed with the SEC is C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.

Insiders trading at Conmed

Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti y Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.



What does Conmed do?

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500



What does Conmed's logo look like?

Conmed Corp. logo

Complete history of Charles Farkas stock trades at Conmed

Fecha
#
Empresa
Persona
Trans.
Transacción
Acciones Precio por acción Precio total Acciones después de Fuente
5 Sep 2024 Charles Farkas
Director
Uso de opción 1,000 $39.64 $39,640
5 Sep 2024
20,880
31 May 2024 Charles Farkas
Director
Uso de opción 302 $76.44 $23,085
31 May 2024
19,880
1 Jun 2023 Charles Farkas
Director
Uso de opción 335 $123.79 $41,470
1 Jun 2023
19,578
1 Jun 2022 Charles Farkas
Director
Uso de opción 812 $111.79 $90,773
1 Jun 2022
19,243
1 Jun 2021 Charles Farkas
Director
Uso de opción 1,521 $138.45 $210,582
1 Jun 2021
18,431
1 Jun 2020 Charles Farkas
Director
Uso de opción 1,407 $73.94 $104,034
1 Jun 2020
16,910
31 May 2019 Charles Farkas
Director
Uso de opción 1,629 $80.48 $131,102
31 May 2019
15,503
1 Jun 2018 Charles Farkas
Director
Uso de opción 2,167 $69.03 $149,588
1 Jun 2018
13,874
3 Jan 2018 Charles Farkas
Director
Comprar 158 $50.61 $7,996
3 Jan 2018
11,707
3 Oct 2017 Charles Farkas
Director
Comprar 148 $53.96 $7,986
3 Oct 2017
11,549
5 Jul 2017 Charles Farkas
Director
Comprar 157 $50.78 $7,972
5 Jul 2017
11,401
1 Jun 2017 Charles Farkas
Director
Uso de opción 2,739 $51.90 $142,154
1 Jun 2017
11,244
3 Apr 2017 Charles Farkas
Director
Comprar 180 $44.41 $7,994
3 Apr 2017
8,505
3 Jan 2017 Charles Farkas
Director
Comprar 305 $44.65 $13,618
3 Jan 2017
8,325
3 Oct 2016 Charles Farkas
Director
Comprar 336 $40.04 $13,453
3 Oct 2016
8,020
1 Jul 2016 Charles Farkas
Director
Comprar 282 $47.87 $13,499
1 Jul 2016
7,684
1 Jun 2016 Charles Farkas
Director
Uso de opción 3,000 $41.06 $123,180
1 Jun 2016
7,402
1 Jun 2016 Charles Farkas
Director
Uso de opción 3,000 $41.06 $123,180
1 Jun 2016
7,402
1 Apr 2016 Charles Farkas
Director
Comprar 338 $42.04 $14,210
1 Apr 2016
4,402
1 Apr 2016 Charles Farkas
Director
Comprar 338 $42.04 $14,210
1 Apr 2016
4,402
4 Jan 2016 Charles Farkas
Director
Comprar 332 $42.18 $14,004
4 Jan 2016
4,064
1 Oct 2015 Charles Farkas
Director
Comprar 292 $47.74 $13,940
1 Oct 2015
3,732
2 Jul 2015 Charles Farkas
Director
Comprar 205 $58.66 $12,025
2 Jul 2015
3,440
1 Jun 2015 Charles Farkas
Director
Uso de opción 3,000 $55.70 $167,100
1 Jun 2015
3,235
1 Apr 2015 Charles Farkas
Director
Comprar 235 $50.74 $11,924
1 Apr 2015
235


Conmed executives and stock owners

Conmed executives and other stock owners filed with the SEC include: